SPC263

Doravirín eða lyfjafræðilega viðunandi salt þar af

  • Status:
    Veitt
  • Application date:
    5.4.2019
  • Application published:
    15.5.2019
  • Grant published:
    15.4.2021
  • Max expiry date:
    26.11.2033
  • Medicine name:
    PIFELTRO
  • Medicine for children:
    No

Timeline

Today
5.4.2019Application
15.5.2019Publication
15.4.2021Registration
26.11.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1332/001-002
  • Date:
    5.12.2018
  • Foreign authorization number:
    EU/1/18/1332
  • Date:
    22.11.2018

Owner

  • Name:
    Merck Canada Inc.
  • Address:
    16711 Trans-Canada Highway, Kirkland, QC H9H 3L1 CA

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents